RU95106400A - Method of prevention and treatment of diphtheria neuropathy in experiment - Google Patents

Method of prevention and treatment of diphtheria neuropathy in experiment

Info

Publication number
RU95106400A
RU95106400A RU95106400/14A RU95106400A RU95106400A RU 95106400 A RU95106400 A RU 95106400A RU 95106400/14 A RU95106400/14 A RU 95106400/14A RU 95106400 A RU95106400 A RU 95106400A RU 95106400 A RU95106400 A RU 95106400A
Authority
RU
Russia
Prior art keywords
treatment
diphtheria
neuropathy
experiment
prevention
Prior art date
Application number
RU95106400/14A
Other languages
Russian (ru)
Inventor
М.Н. Сорокина
Р.А. Насыров
М.В. Давыдовская
Original Assignee
Научно-исследовательский институт детских инфекций
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Научно-исследовательский институт детских инфекций filed Critical Научно-исследовательский институт детских инфекций
Priority to RU95106400/14A priority Critical patent/RU95106400A/en
Publication of RU95106400A publication Critical patent/RU95106400A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

FIELD: medicine. SUBSTANCE: nerve growth factor is administrated in damaged limb at dose determined in experiments. Alternating of indicated factor and diphtheria toxin administration in damaged limb at the definite sequence and time provides significant curative effect. Method can be used at severe damage of peripheral nerves. EFFECT: enhanced effectiveness of treatment.

Claims (1)

Способ может применяться для лечения и улучшения исходов заболеваний при тяжелом повреждении периферических нервов, вызванном дифтерийным токсином. Сущность способа: в пораженную конечность вводят фактор роста нервов в дозе, определенной экспериментально. Чередование ввода указанного фактора и дифтерийного токсина при их введении в пораженную конечность в определенной последовательности и в течение времени, также определенного экспериментально, обеспечивают значительный лечебный эффект.The method can be used to treat and improve disease outcomes in severe damage to peripheral nerves caused by diphtheria toxin. The essence of the method: nerve growth factor is introduced into the affected limb in a dose determined experimentally. The alternation of the introduction of the specified factor and diphtheria toxin when they are introduced into the affected limb in a certain sequence and during a time also experimentally determined provide a significant therapeutic effect.
RU95106400/14A 1995-04-24 1995-04-24 Method of prevention and treatment of diphtheria neuropathy in experiment RU95106400A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU95106400/14A RU95106400A (en) 1995-04-24 1995-04-24 Method of prevention and treatment of diphtheria neuropathy in experiment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU95106400/14A RU95106400A (en) 1995-04-24 1995-04-24 Method of prevention and treatment of diphtheria neuropathy in experiment

Publications (1)

Publication Number Publication Date
RU95106400A true RU95106400A (en) 1997-02-27

Family

ID=48433329

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95106400/14A RU95106400A (en) 1995-04-24 1995-04-24 Method of prevention and treatment of diphtheria neuropathy in experiment

Country Status (1)

Country Link
RU (1) RU95106400A (en)

Similar Documents

Publication Publication Date Title
GEP20002146B (en) Therapeutic Peptide Derivatives
RU94027680A (en) Parathyroid hormone and raloxifen for bone mass increase, pharmaceutical composition and method of osseous mass increase
PT668763E (en) USE OF FENSERIN FOR THE PREPARATION OF MEDICINES TO TREAT DISEASES OF KNOWLEDGE
MY113059A (en) Controlled-release dosage forms of azithromycin
MX9302038A (en) METHOD FOR THE TREATMENT OF CANCER BY A JOINT THERAPY WITH 2-HALOMETILIDENO DERIVATIVES AND A SPECIFIC PHASE M OR PHASE S ANTINEOPLASIC AGENT.
RU94041207A (en) Remedy for treating diseases affecting the nervous system
RU95106400A (en) Method of prevention and treatment of diphtheria neuropathy in experiment
RU94035038A (en) Method for treating disseminated psoriasis
SU1666118A1 (en) Method for treatment of trifacial neurolgia
RU94045317A (en) Method for treatment of encephalomyelitis
RU93043795A (en) METHOD OF TREATING MALIGNANT NUMER FORMATIONS
RU1822775C (en) Method for treatment of trigeminal nerve neuralgia
RU94020918A (en) Method for treating the cases of opsomenorrhea
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
RU94037731A (en) Method for treating multiple sclerosis
RU95101175A (en) Method to treat diseases
RU94035330A (en) Method for treating skin diseases
RU2204982C1 (en) Method for treating patchy baldness
RU94036142A (en) Method of tumor treatment
SU1487907A1 (en) Method of treating ovular paints
RU94010421A (en) Method for treating moderately severe and severe degree facial nerve neuropathy
RU94043033A (en) Method of immunohomeostasis correction and modulation at viscera organs and nervous system sickness
RU94035493A (en) Method for treating diskal lumbosacral and other types of intervertebral hernias
RU94006635A (en) Method for correcting functional state
RU94044795A (en) Method for treating the cases of trifacial neuralgia